Lloyd A Rowland's Net Worth
$3.49 Million
Who is Lloyd A Rowland?
Lloyd A Rowland has an estimated net worth of $3.49 Million. This is based on reported shares across multiple companies, which include Xencor Inc, CytomX Therapeutics, Inc., and AMYLIN PHARMACEUTICALS INC.
SEC CIK
Lloyd A Rowland's CIK is 0001236395
Past Insider Trading and Trends
2006 was Lloyd A Rowland's most active year for acquiring shares with 21 total transactions. Lloyd A Rowland's most active month to acquire stocks was the month of February. 2006 was Lloyd A Rowland's most active year for disposing of shares, totalling 32 transactions. Lloyd A Rowland's most active month to dispose stocks was the month of July. 2019 saw Lloyd A Rowland paying a total of $107,848.33 for 65,712 shares, this is the most they've acquired in one year. In 2012 Lloyd A Rowland cashed out on 322,860.2 shares for a total of $7,994,189.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xencor Inc (XNCR) Snapshot price: $16.18
Sr. V.P. and General CounselLloyd A Rowland owns 1,501 units of Common Stock which is worth $24,286.18. In the year 2014 Lloyd A Rowland filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
∞
| 1.5K |
—
|
—
| 1.5K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
General CounselLloyd A Rowland owns 130,797 units of Common Stock which is worth $156,956.40. From 2018 to 2024 Lloyd A Rowland acquired a total of 136,791 shares in CytomX Therapeutics, Inc. at a cost of $119,332.00, Lloyd also disposed a total of 26,651 shares of CytomX Therapeutics, Inc. equalling to $40,888.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.71% | 7.07K |
$1.23 | -$5,138.87 | 130.8K |
Aug 20
| |||
Form 4
| -4.28% | -5.27K |
$2.09 | -$10,986.41 | 117.73K |
Mar 19
| |||
Form 4
| +25.51% | 25K |
—
|
—
| 123K |
Jan 18
| |||
Form 4
| -3.99% | -4.08K |
$1.38 | -$5,629.11 | 98K |
Dec 20
| |||
Form 4
| +12.39% | 11.25K |
—
|
—
| 102.07K |
Dec 17
| |||
Form 4
| +13.38% | 9.51K |
$1.30 | -$7,135.09 | 80.61K |
Sep 20 - Sep 22
| |||
Form 4
| -2.79% | -2.04K |
$1.98 | -$4,031.22 | 71.09K |
Mar 16
| |||
Form 4
| +51.94% | 25K |
—
|
—
| 73.13K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +27.41% | 9.4K |
$1.42 | -$7,967.72 | 43.69K |
Jul 19 - Jul 20
| |||
Form 4
| +190.82% | 22.5K |
—
|
—
| 34.29K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +18.16% | 1.81K |
$8.21 | $14,878.33 | 11.79K |
May 31
| |||
Form 4
| +919.31% | 9K |
$10.33 | $92,970.00 | 9.98K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
∞
| 979 |
$11.73 | $11,483.67 | 979 |
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMYLIN PHARMACEUTICALS INC No price found
VP, Chief Compliance OfficerLloyd A Rowland used to own units in Common Stock but no longer holds any shares there. From 2006 to 2010 Lloyd A Rowland acquired a total of 112,159 shares in AMYLIN PHARMACEUTICALS INC at a cost of $877,942.34, Lloyd also disposed a total of 125,428.2 shares of AMYLIN PHARMACEUTICALS INC equalling to $4,269,577.05.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -47.07K |
$31.00 | -$1,459,033.60 |
0
|
Aug 8
| |||
Form 4
| +2.38% | 823 |
$14.62 | $12,032.26 | 35.43K |
Jul 25
| |||
Form 4
| -7.98% | -3.00K |
$16.33 | -$144,050.00 | 34.6K |
Scheduled
|
Mar 28 - Mar 29
| ||
Form 4
| +22.03% | 8.23K |
—
|
—
| 45.58K |
Mar 6
| |||
Form 4
| -5.41% | -1.77K |
—
|
—
| 30.9K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| -13.51% | -5.00K |
—
|
—
| 32.01K |
Feb 8
| |||
Form 4
| +38.63% | 11.93K |
—
|
—
| 42.81K |
Mar 1
| |||
Form 4
| +5.96% | 1.77K |
$17.83 | $7,345.96 | 31.5K |
Feb 2 - Feb 3
| |||
Form 4
| +281.77% | 2.55K |
—
|
—
| 3.46K |
Mar 4
| |||
Form 4
| +2.39% | 585 |
$11.80 | $6,903.00 | 25.11K |
Feb 3
| |||
Form 4
|
—
|
0
|
$25.77 | -$1,846.00 | 24.43K |
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +0.76% | 182 |
$37.00 | $6,734.00 | 23.98K |
Feb 1
| |||
Form 4
|
—
|
0
|
$27.05 | -$42,030.00 | 23.84K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$30.35 | -$55,231.00 | 23.84K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$33.11 | -$66,260.60 | 23.48K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$34.03 | -$59,864.85 | 23.48K |
Scheduled
|
Sep 4
| ||
Form 4
|
—
|
0
|
$32.58 | -$54,922.60 | 23.48K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$29.93 | -$44,300.00 | 23.48K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$32.75 | -$55,580.00 | 23.48K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$26.73 | -$147,740.00 | 23.48K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$24.45 | -$50,001.40 | 23.48K |
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +1.07% | 248 |
$25.84 | -$42,670.37 | 23.48K |
Scheduled
|
Feb 28 - Mar 1
| ||
Form 4
| +1.82% | 416 |
$27.51 | -$38,934.88 | 23.24K |
Scheduled
|
Jan 31 - Feb 1
| ||
Form 4
| +15.14% | 3K |
$22.16 | -$31,110.00 | 22.82K |
Scheduled
|
Jan 3
| ||
Form 4
| -0.68% | -135.00 |
—
|
—
| 19.82K |
Dec 18
| |||
Form 4
|
—
|
0
|
$25.67 | -$54,880.00 | 19.96K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$24.87 | -$76,560.00 | 19.96K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$24.40 | -$74,687.80 | 19.96K |
Scheduled
|
Oct 2
| ||
Form 4
|
—
|
0
|
$25.42 | -$79,170.00 | 19.49K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$26.51 | -$83,683.80 | 19.49K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$26.81 | -$84,860.60 | 19.49K |
Scheduled
|
Jul 3
| ||
Form 4
| +11.43% | 2K |
$5.59 | $11,180.00 | 19.49K |
Jun 29
| |||
Form 4
| +12.91% | 2K |
$5.59 | $11,180.00 | 17.49K |
Jun 12
| |||
Form 4
|
—
|
0
|
$25.58 | -$79,960.00 | 15.49K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
$24.30 | -$74,820.00 | 15.49K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$26.24 | -$82,590.00 | 15.49K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$24.30 | -$112,230.00 | 15.49K |
Scheduled
|
Mar 1
| ||
Form 4
| +6.12% | 893 |
$25.51 | $22,777.02 | 15.49K |
Jan 31
| |||
Form 4
|
—
|
0
|
$23.65 | -$108,350.10 | 14.6K |
Scheduled
|
Feb 1
| ||
Form 4
| +15.87% | 2K |
$5.59 | $11,180.00 | 14.6K |
Jan 17
| |||
Form 4/A
|
—
|
0
|
$22.92 | -$34,670.00 | 12.6K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$22.68 | -$188,005.00 | 12.6K |
Scheduled
|
Dec 30 - Jan 3
| ||
Form 4
|
—
|
0
|
$21.60 | -$80,025.00 | 12.6K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$19.35 | -$68,775.00 | 12.6K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$20.87 | -$76,402.00 | 12.6K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +25.74% | 2.5K |
$5.59 | $13,975.00 | 12.21K |
Feb 14
| |||
Form 4
|
—
|
0
|
$14.53 | -$44,700.00 | 8.73K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$14.10 | -$42,518.75 | 8.73K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
$17.12 | -$115,300.00 | 5.1K |
Sep 5
| |||
| No matching records found | |||||||||